Key result
Fasting proinsulin was significantly associated with concurrently measured triglycerides (r=0.18, P<0.0001), and baseline triglycerides predicted changes in proinsulin over time (r=0.23, P=0.04).
Observational (n=579)
No
Effect estimate: r = 0.18
p-value: p=<0.0001
Proinsulin levels are cross-sectionally associated with lipid concentrations, and baseline lipids are prospectively associated with changes in proinsulin over time in a Native Canadian population.
Triglyceride-proinsulin associations warrant no practice change; leaves open causal direction and need for prospective validation.
OBJECTIVE: To examine cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors using data from a population-based study of type 2 diabetes among Native Canadians. RESEARCH DESIGN AND METHODS: Between 1993 and 1995, 72% of eligible members of a Native Canadian community participated in a baseline diabetes prevalence survey. Fasting samples were collected for glucose, C-peptide, proinsulin, lipids, and apolipoproteins. A 75-g oral glucose tolerance test was administered, and a second sample for glucose was drawn after 120 min. Blood pressure and waist circumference were determined. In the present study, subjects with normal glucose tolerance (NGT) (n = 505) and impaired glucose tolerance (IGT) (n = 74) were included in cross-sectional analyses. In 1998, 95 individuals who had IGT or NGT at baseline with an elevated 2-h glucose concentration (> or = 7.0 mmol/l) participated in a follow-up evaluation using the protocol used at baseline. Cross-sectional and prospective associations between proinsulin and cardiovascular risk factors were assessed using correlation and multiple linear regression analyses. RESULTS: After adjustment for covariates including age, sex, C-peptide, waist circumference, and glucose tolerance status, fasting proinsulin concentration was significantly associated with concurrently measured lipid and apolipoprotein concentrations (triglycerides: r = 0.18, P < 0.0001; total cholesterol: r = 0.10, P = 0.02; LDL cholesterol: r = 0.11, P = 0.01; HDL cholesterol: r = -0.16, P = 0.0002; apolipoprotein (apo) B: r = 0.17, P < 0.0001; apoAI: r = -0.11, P = 0.008). In the adjusted prospective analysis, baseline triglycerides, HDL cholesterol, and apoB were associated with changes over time in proinsulin (r = 0.23, P = 0.04; r = -0.30, P = 0.01; r = 0.23, P = 0.04; respectively). CONCLUSIONS: These results confirm previously reported cross-sectional associations between proinsulin and lipid concentrations. In addition, an unexpected association between baseline lipids and proinsulin change was documented.
No takes yet. Share an insight, caveat, or question.
Hanley et al. (2001) conducted an observational in Cardiovascular disease risk factors (n=579). Proinsulin was evaluated on Cross-sectional and prospective associations between proinsulin and cardiovascular risk factors (r = 0.18, p=<0.0001). Fasting proinsulin was significantly associated with concurrently measured triglycerides (r=0.18, P<0.0001), and baseline triglycerides predicted changes in proinsulin over time (r=0.23, P=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: